AstraZeneca (AZN) Expands Oncology Portfolio with $600M Lung Cancer Drug Acquisition
Related Stocks: AZN
Read the full article3d agoen
You might also wanna read
Yara International (YARIY) Reports Strong Q2 Earnings with Revenue Growth
GuruFocus·39m ago
Goldman Sachs (GS) Tops M&A Advisory Rankings in H1 2026
GuruFocus·40m ago
STAAR Surgical (STAA) Shares Drop Despite Strong Q2 Revenue
GuruFocus·40m ago
AB SKF (SKFRY) Reports Q2 Earnings with Positive Outlook Despite Geopolitical Concerns
GuruFocus·40m ago
UBS Maintains Bullish Outlook for S&P 500, Targets 7900
GuruFocus·42m ago
Seven & I Holdings (SVND) Eyes Expansion with Potential Zabka Acquisition
GuruFocus·43m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.